Workshop on Innovation in Regenerative Medicine
On December 6-7, 2017, the NIH and FDA will host a Regenerative Medicine Innovation Workshop. The meeting will explore the state of regenerative medicine and the underlying science. The focus will be on approaches to the development of safe and effective products utilizing adult stem cells.
Sessions will emphasize issues with broad applicability to many areas of clinical research in regenerative medicine. Presentations and case studies will focus on product development and clinical applications in specific clinical disciplines. There will also be sessions dedicated to topics and opportunities in preclinical studies and clinical trial development pertinent to regulatory issues. Panel discussions will cover scientific, technical and operational challenges that need to be addressed, to enable the development of clinical applications using adult stem cells.
An agenda, registration and additional information are available on the Workshop website.